HeimDIVISLAB • NSE
add
Divi's Laboratories Ltd
Við síðustu lokun
5.977,10 ₹
Dagbil
5.980,00 ₹ - 6.056,95 ₹
Árabil
3.350,00 ₹ - 6.275,85 ₹
Markaðsvirði
1,59 bn INR
Meðalmagn
499,58 þ.
V/H-hlutf.
86,78
A/V-hlutfall
0,50%
Aðalkauphöll
NSE
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (INR) | sep. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 23,38 ma. | 22,47% |
Rekstrarkostnaður | 7,52 ma. | 5,17% |
Nettótekjur | 5,10 ma. | 46,55% |
Hagnaðarhlutfall | 21,81 | 19,64% |
Hagnaður á hvern hlut | 19,51 | 48,82% |
EBITDA | 7,15 ma. | 49,58% |
Virkt skatthlutfall | 29,36% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (INR) | sep. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 36,02 ma. | -0,25% |
Heildareignir | 155,86 ma. | 9,12% |
Heildarskuldir | 18,69 ma. | 16,38% |
Eigið fé alls | 137,17 ma. | — |
Útistandandi hlutabréf | 265,62 m. | — |
Eiginfjárgengi | 11,57 | — |
Arðsemi eigna | — | — |
Ávöxtun eigin fjár | 11,30% | — |
Peningaflæði
Breyting á handbæru fé
| (INR) | sep. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | 5,10 ma. | 46,55% |
Handbært fé frá rekstri | — | — |
Reiðufé frá fjárfestingum | — | — |
Reiðufé frá fjármögnun | — | — |
Breyting á handbæru fé | — | — |
Frjálst peningaflæði | — | — |
Um
Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients and intermediates, headquartered in Hyderabad. The company manufactures and custom synthesizes generic APIs, intermediates. The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization.
In October 2024, Divi and his family were ranked 29th on Forbes list of India’s 100 richest tycoons, with a net worth of $9.2 billion. Wikipedia
Framkvæmdastjóri
Stofnsett
12. okt. 1990
Vefsvæði
Starfsfólk
9.741
